Dr. Shunan Chen earned his Ph.D. in 2022 and subsequently joined the Institute of Chemistry, Chinese Academy of Sciences (ICCAS), where he conducts research at the intersection of nanotechnology and molecular biology. His work focuses on developing targeted therapies for Alzheimer’s disease, glioma, and epilepsy. Committed to addressing unmet clinical needs, Dr. Chen has successfully led multiple translational medicine projects, effectively bridging fundamental neuroscience with clinical application.
China
Chen Shunan
Institute of Chemistry Chinese Academy of Sciences
Committee Member
